The largest database of trusted experimental protocols

Huvecs

Manufactured by Keygen Biotech
Sourced in China

HUVECs are primary human umbilical vein endothelial cells. They are a commonly used in vitro cell model for studying endothelial cell biology and angiogenesis.

Automatically generated - may contain errors

23 protocols using huvecs

1

Antioxidant Pretreatment Modulates PCB Exposure

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs and human monocytic cells (THP-1 cells) were purchased from KeyGEN Biotech Co., Ltd. HUVECs and THP-1 cells were grown in Roswell Park Memorial Institute 1640 medium supplemented with 10% fetal bovine serum (Zhejiang Tianhang Biotechnology Co., Ltd.), 100U/mL penicillin, and 100μg/mL streptomycin at 37°C in a 5% CO2 incubator. In addition, the medium for THP-1 cells was supplemented with 50μM
β-mercaptoethanol . HUVECs ( 1×106 ) were seeded in six-well culture plates overnight and exposed to 5μM PCB29-pQ for 24 h for subsequent experimental testing. HUVECs were pretreated with antioxidants ( 40μM VC, 20μM VE, 5 mM NAC, 200U/mL PEG-SOD, 500U/mL PEG-CAT, or 5 mM GSH-MEE) for 1 h, followed with 5μM PCB29-pQ exposure for 6 h for subsequent experimental testing. Parallel control cultures received equal volumes of dimethyl sulfoxide (DMSO). Each experiment was independently repeated at least three times.
+ Open protocol
+ Expand
2

Human Trophoblast Cell Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four human trophoblast cell lines (HTR/SVneo, JAR, JEG3, and BeVo) and HUVECs were purchased from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). HTR/SVneo and JAR cells were cultured in RPMI1640, JEG3 cells in MEM, BeVo cells in F12K, and HUVECs in endothelial cell medium (ECM) (all media from KeyGEN, Nanjing, China) supplemented with 10% fetal bovine serum (FBS) (Gibco-BRL, Invitrogen, Carlsbad, CA, USA), 100 U/mL penicillin, and 100 mg/mL streptomycin (Invitrogen). All cells were maintained in a humidified atmosphere with 5% CO2 at 37°C.
+ Open protocol
+ Expand
3

HUVEC Culture and Conditioned Media Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs) were obtained from Keygen biotech (Nanjing, China). Cells were maintained in DMEM:F12K medium (Gibco, GrandIsland, NY) containing 10% (v/v) fetal bovine serum (FBS) (Hyclone, Logan, UT), 100 units penicillin/mL, 100 mg/mL streptomycin,0.1mg/mL heparin and 0.05mg/mL endothelial cell growth supplement (ECGS) in a humidified atmosphere at 37°C with 5% CO2. Confluent cultures between passages 2–3 were used in this study to minimize age-dependent variation in the level of apoptosis. Conditioned medium (CM) was collected in sterile conditions followed by centrifugation at 3000 rpm for 20 min at 4°C, and then stored at −80°C for further use. CM1 and CM2 are self conditioned media collected from the culture medium of HUVECs-transfected with empty vector and Mxi1-0 plasmid, respectively. Complete medium alone without cells was incubated under the same experimental conditions served as control.
+ Open protocol
+ Expand
4

Apoptosis Analysis of HUVECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs) were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured in Roswell Park Memorial Institute 1640 medium supplemented with 10% fetal bovine serum in an incubator with 37°C and 5% CO2.
Apoptosis analysis of HUVECs was performed by flow cytometry according to manufacturer’s instructions. Briefly, treated or untreated HUVECs were collected and labeled with Annexin V-APC/7-AAD apoptosis detection kit (KeyGen Biotech, Jiangsu, People’s Republic of China), followed by flow cytometry analysis.
For p53 immunofluorescence, HUVECs were seeded on coverslips in a 24-well plate. After treating HUVECs with 0 (control), 30, and 60 μg/mL PEG-b-PCL nano-micelles for 24 hours, the cells were fixed with 4% PFA for 30 minutes, permeabilized with 0.1% Triton X–100 for 10 minutes, and blocked with 5% bovine serum albumin for 1 hour. After blocking, the cells were stained with p53 antibody (rabbit, Santa Cruz Biotechnology Inc, Dallas, TX, USA) overnight at 4°C, followed by 1 hour incubation with anti-rabbit secondary antibody and 4′,6-diamidino-2-phenylindole at room temperature. Samples were imaged using a fluorescence microscopy (Olympus BX81; Olympus).
+ Open protocol
+ Expand
5

Engineered Hydrogel for Vascular Cell Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
GelMA with photoinitiator, lithium phenyl‐2,4,6‐trimethylbenzoylphosphinate, was purchased from Intelligent Manufacturing Research Institute (IMRI, GM‐90, Suzhou, China). TNF‐α, ox‐LDL, and IL‐1β were purchased from Sigma‐Aldrich (St. Louis, USA). DAPI, HUVECs, human SMCs, and actin‐tracker green were purchased from Keygen Biotech Co., Ltd. (Nanjing, China). Paraformaldehyde (4% w/v), Triton X‐100, CCK‐8, and phosphate‐buffered saline (PBS) were purchased from Solarbio (Beijing, China). Mouse MCs were purchased from Kemao Biotechnology (Dongguan, China). Penicillin–streptomycin, Dulbecco's modified Eagle medium (DMEM), fetal bovine serum (FBS), and endothelial basal medium (F‐12K) were purchased from Gibco (Grand Island, USA). Cell labeling kits (Qtracker 525 and 655), α‐SMA, VE‐Cad primary polyclonal antibody, and goat anti‐rabbit IgG (H+L) secondary antibody were obtained from Thermo Fisher (Waltham, USA).
+ Open protocol
+ Expand
6

Endothelial Cell Injury Model Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs were purchased from KeyGen BioTECH Corp., Ltd (Nanjing, China) and grown in DMEM (11995065, Thermo Fisher Scientific, San Jose, USA) with 5% CO2 at 37℃. The model of endothelial cell injury was constructed with 10 ng/mL TNF-α for 24 h. Overexpression plasmids, pcDNA3.1-ALKBH5 and pcDNA3.1-Bcl2 were purchased from YouBio (Changsha, China). The siRNA-Bcl2 and siRNA-control were synthetized from Sangon Biotech (Shanghai, China). Lipofectamine 2000 (11668500, Thermo Fisher Scientific, San Jose, USA) was used for the transfection. miR-7 mimic (5′-TGGAAGACTAGTGATTTTGTTG-3′) and negative control (NC) mimic (5′-GGUUCGUACGUACACUGUUCA-3′) were synthetized from GeneChem Co., Ltd (Shanghai, China).
+ Open protocol
+ Expand
7

HUVEC Manipulation and TNF-α Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human Umbilical Vein Endothelial Cells (HUVECs), obtained from Jiangsu KeyGEN BioTECH (KeyGEN, KG419), were cultured in Ham's F‐12K medium (Gibco, 21127030) with 1% Endothelial Cell Growth Supplement (ECGS) (KeyGEN, KGY1052), 1% penicillin‐streptomycin, 10% fetal bovine serum (Gibco, 10099141), and .1 mg/mL heparin (KeyGEN, KGY3149H) at 37°C in a humidified atmosphere containing 5% CO2. After being seeded on appropriate culture plates overnight, HUVECs were exposed to 100 ng/mL tumour necrosis factor‐α (TNFα) (Novoprotein, C008) for different time periods.
Rictor gene knockout of HUVECs and corresponding control cells were generated using the CRISPR/Cas9 system obtained from Hanbio biotechnology. Rictor gene knockout of HUVECs were confirmed by sequencing and validated by western blotting. For Rictor overexpression, HUVECs were transfected with either Empty vector lentivirus or Flag‐Rictor lentivirus (Genechem) following the manufacturer's instruction.
+ Open protocol
+ Expand
8

Isolation and Culture of EC and HUVEC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human EC cell lines (Ishikawa and RL95-2) were obtained from American Type Culture Collection (ATCC, Manassas, VA). Human umbilical vascular endothelial cells (HUVECs) were obtained from Key-GEN Biotech (Nanjing, China). Ishikawa and RL95-2 cells were grown in DMEM/F12 (Gibco, Auckland, NZ) supplemented with 10% fetal bovine serum (Gibco, Carlsbad, CA). HUVECs were cultured in RPMI1640 (Gibco) supplemented with 10% fetal bovine serum. Cells were cultured in a 5% CO2 humidified incubator at 37°C. For hypoxia experiments, cells were grown in an in vitro hypoxic (<0.1% O2) container system (BD Diagnostics, Sparks, MD). Conditioned medium (CM), protein and RNA were collected immediately when cells were removed from hypoxic container.
+ Open protocol
+ Expand
9

Cell Line Characterization and Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human RCC cell lines 786-O and OS-RC-2 were purchased from the Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (Shanghai, China). Human umbilical vascular endothelial cells (HUVECs) were obtained from Key-GEN biotech (Nanjing, China). 786-O, OS-RC-2 and HUVEC cells were cultured in RPMI1640 medium supplemented with 10% fetal calf serum (Invitrogen, Shanghai, China). Cells were in a 37 °C humidified incubator with 5% CO2. The CHIP overexpression plasmids were obtained from Dr. Shouyu Wang (Nanjing Medical University, Jiangsu, China). non-specific control siRNA or CHIP siRNA was purchased from GenePharma biotech (Shanghai, China). Transfection of the plasmids into the renal carcinoma cells were carried out using Lipofectamine 2000 transfection reagent (Invitrogen, Shanghai, China) following the manufacturer’s protocol. Transfection of the non-specific control siRNA or CHIP siRNA were carried out using siLentFect Lipid Reagent (Bio-Rad, Hercules, CA, USA) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
10

HUVEC Culture Optimization Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs (KeyGen, China) were cultured in RPMI.1640 medium (KeyGen BioTECH, China) supplemented with 10% Fetal Bovine Serum (Gibco, Life technologies, US), 80 U/ml penicillin, and 0.08 mg/ml streptomycin as recommended by the supplier. They were incubated at 37 °C in humidified atmosphere containing 5% CO2 and 95% air. After reaching 80% confluence, cells were passaged by 0.25 wt.% trypsin-EDTA solution (Gibco, US). Cells at passages 3 to 10 were used for subsequent experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!